Skip to main content
Premium Trial:

Request an Annual Quote

Alacris Attains Illumina CSPro Certification for NGS

NEW YORK (GenomeWeb News) – Alacris Theranostics today said that is has gained Illumina CSPro certification for next-generation sequencing.

Illumina CSPro is a collaborative service provider partnership aimed at providing high quality data for genetic analysis applications, and applicants undergo a two-phase process that includes minimum data generation, data certification, and an onsite audit of the facility and processes.

Based in Berlin, Alacris specializes in personalized medicine for cancer patient diagnosis, treatment, and stratification, it said on its website. It uses a systems biology approach, called ModCell, developed at the Max Planck Institute for Molecular Genetics and licensed to Alacris. The approach is based on next-generation sequencing to provide information about the genome and transcriptome, and incorporates kinetic pathway information, and mutation and drug databases.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.